Mobility assessment in people with Alzheimer disease using smartphone sensors

[EN] Background Understanding the functional status of people with Alzheimer Disease (AD), both in a single (ST) and cognitive dual task (DT) activities is essential for identifying signs of early-stage neurodegeneration. This study aims to compare the performance quality of several tasks using sensors embedded in an Android device, among people at different stages of Alzheimer and people without dementia. The secondary aim is to analyze the effect of cognitive task performance on mobility tasks. Methods This is a cross-sectional study including 22 participants in the control group (CG), 18 in the group with mild AD and 22 in the group with moderate AD. They performed two mobility tests, under ST and DT conditions, which were registered using an Android device. Postural control was measured by medial-lateral and anterior-posterior displacements of the COM (MLDisp and APDisp, respectively) and gait, with the vertical and medial-lateral range of the COM (Vrange and MLrange). Further, the sit-to-stand (PStand) and turning and sit power (PTurnSit), the total time required to complete the test and the reaction time were measured. Results There were no differences between the two AD stages either for ST or DT in any of the variables (p > 0.05). Nevertheless, people at both stages showed significantly lower values of PStand and PTurnSit and larger Total time and Reaction time compared to CG (p < 0.05). Further, Vrange is also lower in CDR1G than in CG (p < 0.05). The DT had a significant deleterious effect on MLDisp in all groups (p < 0.05) and on APDisp only in moderate AD for DT. Conclusions Our findings indicate that AD patients present impairments in some key functional abilities, such as gait, turning and sitting, sit to stand, and reaction time, both in mild and moderate AD. Nevertheless, an exclusively cognitive task only influences the postural control in people with AD.This work was funded by the Spanish Government, Secretaria de Estado de Investigacion, Desarrollo e Innovacion, and co-financed by EU FEDER funds (Grant DPI2013-44227-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Serra-Añó, P.; Pedrero, J.; Hurtado-Abellán, J.; Inglés, M.; Espí-López, G.; Lopez Pascual, J. (2019). Mobility assessment in people with Alzheimer disease using smartphone sensors. Journal of NeuroEngineering and Rehabilitation. 16(1). https://doi.org/10.1186/s12984-019-0576-yS161Association A. 2017 Alzheimer’s disease facts and figures. Alzheimers Dement. 2017;13(4):325–73.Harrington MG, Chiang J, Pogoda JM, Gomez M, Thomas K, Marion SD, et al. Executive function changes before memory in preclinical Alzheimer’s pathology: a prospective, cross-sectional, case control study. PLoS One. 2013;8(11):e79378.Buckner RL. Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron. 2004;44(1):195–208.Beauchet O, Launay CP, Barden J, Liu-Ambrose T, Chester VL, Szturm T, et al. Association between falls and brain subvolumes: results from a cross-sectional analysis in healthy older adults. Brain Topogr. 2017;30(2):272–80.Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord Off J Mov Disord Soc. 2008;23(3):329–42.Verghese J, Wang C, Holtzer R, Lipton R, Xue X. Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry. 2007;78(9):929–35.Beauchet O, Annweiler C, Callisaya ML, De Cock A-M, Helbostad JL, Kressig RW, et al. Poor gait performance and prediction of dementia: results from a meta-analysis. J Am Med Dir Assoc. 2016;17(6):482–90.Rucco R, Agosti V, Jacini F, Sorrentino P, Varriale P, De Stefano M, et al. Spatio-temporal and kinematic gait analysis in patients with frontotemporal dementia and Alzheimer’s disease through 3D motion capture. Gait Posture. 2017;52:312–7.de Melo Coelho FG, Stella F, de Andrade LP, Barbieri FA, Santos-Galduróz RF, Gobbi S, et al. Gait and risk of falls associated with frontal cognitive functions at different stages of Alzheimer’s disease. Aging Neuropsychol Cogn. 2012;19(5):644–56.Beauchet O, Allali G, Launay C, Herrmann FR, Annweiler C. Gait variability at fast-pace walking speed: a biomarker of mild cognitive impairment? J Nutr Health Aging. 2013;17(3):235–9.Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ. Will my patient fall? JAMA. 2007;297(1):77–86.Egerton T, Danoudis M, Huxham F, Iansek R. Central gait control mechanisms and the stride length - cadence relationship. Gait Posture. 2011;34(2):178–82.Baddeley AD, Baddeley HA, Bucks RS, Wilcock GK. Attentional control in Alzheimer’s disease. Brain. 2001;124(8):1492–508.Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS–ADRDA criteria. Lancet Neurol. 2007;6(8):734–46.Coubard OA, Ferrufino L, Boura M, Gripon A, Renaud M, Bherer L. Attentional control in normal aging and Alzheimer’s disease. Neuropsychology. 2011;25(3):353–67.Ries JD, Echternach JL, Nof L, Gagnon BM. Test-retest reliability and minimal detectable change scores for the timed “up & go” test, the six-minute walk test, and gait speed in people with Alzheimer disease. Phys Ther. 2009;89(6):569–79.Tamura K, Kocher M, Finer L, Murata N, Stickley C. Reliability of clinically feasible dual-task tests: expanded timed get up and go test as a motor task on young healthy individuals. Gait Posture. 2018;60:22–7.Muir SW, Speechley M, Wells J, Borrie M, Gopaul K, Montero-Odasso M. Gait assessment in mild cognitive impairment and Alzheimer’s disease: the effect of dual-task challenges across the cognitive spectrum. Gait Posture. 2012;35(1):96–100.Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–4.Ansai JH, Andrade LP, Rossi PG, Takahashi AC, Vale FA, Rebelatto JR. Gait, dual task and history of falls in elderly with preserved cognition, mild cognitive impairment, and mild Alzheimer’s disease. Braz J Phys Ther. 2017;21(2):144–51.Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry. 2003;25(4):277–83.Bower ES, Wetherell JL, Merz CC, Petkus AJ, Malcarne VL, Lenze EJ. A new measure of fear of falling: psychometric properties of the fear of falling questionnaire revised (FFQ-R). Int Psychogeriatr. 2015;27(7):1121–33.López-Pascual J, Hurtado AJ, Inglés M, Espí-López G, Serra-Añó P. P 151-reliability of variables measured with an android device during a modified timed up and go test in patients with Alzheimer’s disease. Gait Posture. 2018;65:484.Nishiguchi S, Yamada M, Nagai K, Mori S, Kajiwara Y, Sonoda T, et al. Reliability and validity of gait analysis by android-based smartphone. Telemed J E Health. 2012;18(4):292–6.Zijlstra W, Hof AL. Assessment of spatio-temporal gait parameters from trunk accelerations during human walking. Gait Posture. 2003;18(2):1–10.Ribeiro JG, De Castro JT, Freire JL. Using the FFT-DDI method to measure displacements with piezoelectric, resistive and ICP accelerometers. In: Conference and exposition on structural dynamics. Rio de Janeiro: Citeseer; 2003.Prieto TE, Myklebust JB, Hoffmann RG, Lovett EG, Myklebust BM. Measures of postural steadiness: differences between healthy young and elderly adults. Biomed Eng IEEE Trans On. 1996;43(9):956–66.Esser P, Dawes H, Collett J, Howells K. IMU: inertial sensing of vertical CoM movement. J Biomech. 2009;42(10):1578–81.Gordon KE, Ferris DP, Kuo AD. Metabolic and mechanical energy costs of reducing vertical center of mass movement during gait. Arch Phys Med Rehabil. 2009;90(1):136–44.Gard SA, Miff SC, Kuo AD. Comparison of kinematic and kinetic methods for computing the vertical motion of the body center of mass during walking. Hum Mov Sci. 2004;22(6):597–610.Weinert-Aplin RA, Twiste M, Jarvis HL, Bennett AN, Baker RJ. Medial-lateral centre of mass displacement and base of support are equally good predictors of metabolic cost in amputee walking. Gait Posture. 2017;51:41–6.Chen S-H, Lo O-Y, Kay T, Chou L-S. Concurrent phone texting alters crossing behavior and induces gait imbalance during obstacle crossing. Gait Posture. 2018;62:422–5.Lindemann U, Claus H, Stuber M, Augat P, Muche R, Nikolaus T, et al. Measuring power during the sit-to-stand transfer. Eur J Appl Physiol. 2003;89(5):466–70.Manckoundia P, Mourey F, Pfitzenmeyer P, Papaxanthis C. Comparison of motor strategies in sit-to-stand and back-to-sit motions between healthy and Alzheimer’s disease elderly subjects. Neuroscience. 2006;137(2):385–92.Christ BU, Combrinck MI, Thomas KG. Both reaction time and accuracy measures of Intraindividual variability predict cognitive performance in Alzheimer’s disease. Front Hum Neurosci. 2018;12:124–35.Vienne A, Barrois RP, Buffat S, Ricard D, Vidal P-P. Inertial sensors to assess gait quality in patients with neurological disorders: a systematic review of technical and analytical challenges. Front Psychol. 2017;8:817.Wang W-H, Chung P-C, Yang G-L, Lin C-W, Hsu Y-L, Pai M-C. An inertial sensor based balance and gait analysis system. In: 2015 IEEE International Symposium on Circuits and Systems (ISCAS): Rio de Janeiro: IEEE; 2015. p. 2636–9.Wüest S, Masse F, Aminian K, Gonzenbach R, De Bruin ED. Reliability and validity of the inertial sensor-based timed “up and go” test in individuals affected by stroke. J Rehabil Res Dev. 2016;53(5):599–610.Nguyen H, Lebel K, Boissy P, Bogard S, Goubault E, Duval C. Auto detection and segmentation of daily living activities during a timed up and go task in people with Parkinson’s disease using multiple inertial sensors. J Neuroengineering Rehabil. 2017;14(1):26.Ansai JH, de Andrade LP, Rossi PG, Nakagawa TH, Vale FAC, Rebelatto JR. Differences in timed up and go subtasks between older people with mild cognitive impairment and mild Alzheimer’s disease. Mot Control. 2018;27:1–12.Eggermont LH, Gavett BE, Volkers KM, Blankevoort CG, Scherder EJ, Jefferson AL, et al. Lower-extremity function in cognitively healthy aging, mild cognitive impairment, and Alzheimer’s disease. Arch Phys Med Rehabil. 2010;91(4):584–8.Leandri M, Cammisuli S, Cammarata S, Baratto L, Campbell J, Simonini M, et al. Balance features in Alzheimer’s disease and amnestic mild cognitive impairment. J Alzheimers Dis. 2009;16(1):113–20.Nakamura T, Meguro K, Yamazaki H, Okuzumi H, Tanaka A, Horikawa A, et al. Postural and gait disturbance correlated with decreased frontal cerebral blood flow in Alzheimer disease. Alzheimer Dis Assoc Disord. 1997;11(3):132–9.Cavagna GA, Margaria R. Mechanics of walking. J Appl Physiol. 1966;21(1):271–8.Ganea R, Paraschiv-Ionescu A, Büla C, Rochat S, Aminian K. Multi-parametric evaluation of sit-to-stand and stand-to-sit transitions in elderly people. Med Eng Phys. 2011;33(9):1086–93.Cameron DM, Bohannon RW, Garrett GE, Owen SV, Cameron DA. Physical impairments related to kinetic energy during sit-to-stand and curb-climbing following stroke. Clin Biomech. 2003;18(4):332–40.McGuinness B, Barrett SL, Craig D, Lawson J, Passmore AP. Attention deficits in Alzheimer’s disease and vascular dementia. J Neurol Neurosurg Psychiatry. 2010;81(2):157–9.Phillips M, Rogers P, Haworth J, Bayer A, Tales A. Intra-individual reaction time variability in mild cognitive impairment and Alzheimer’s disease: gender, processing load and speed factors. PLoS One. 2013;8(6):e65712

Spatial Analysis of the Relationship between Mortality from Cardiovascular and Cerebrovascular Disease and Drinking Water Hardness

Previously published scientific papers have reported a negative correlation between drinking water hardness and cardiovascular mortality. Some ecologic and case–control studies suggest the protective effect of calcium and magnesium concentration in drinking water. In this article we present an analysis of this protective relationship in 538 municipalities of Comunidad Valenciana (Spain) from 1991–1998. We used the Spanish version of the Rapid Inquiry Facility (RIF) developed under the European Environment and Health Information System (EUROHEIS) research project. The strategy of analysis used in our study conforms to the exploratory nature of the RIF that is used as a tool to obtain quick and flexible insight into epidemiologic surveillance problems. This article describes the use of the RIF to explore possible associations between disease indicators and environmental factors. We used exposure analysis to assess the effect of both protective factors—calcium and magnesium—on mortality from cerebrovascular (ICD-9 430–438) and ischemic heart (ICD-9 410–414) diseases. This study provides statistical evidence of the relationship between mortality from cardiovascular diseases and hardness of drinking water. This relationship is stronger in cerebrovascular disease than in ischemic heart disease, is more pronounced for women than for men, and is more apparent with magnesium than with calcium concentration levels. Nevertheless, the protective nature of these two factors is not clearly established. Our results suggest the possibility of protectiveness but cannot be claimed as conclusive. The weak effects of these covariates make it difficult to separate them from the influence of socioeconomic and environmental factors. We have also performed disease mapping of standardized mortality ratios to detect clusters of municipalities with high risk. Further standardization by levels of calcium and magnesium in drinking water shows changes in the maps when we remove the effect of these covariates

VME indicator species collected during exploratory fishing in Macaronesian seamounts

During the second half of 2012, the longline vessel MARANSA completed 13 fishing trips in international waters of CECAF Area (Division FAO 34), in nine Seamounts from northeast off Madeira (Lion, Ampere, Unicorn, Seine, “Camaguay”, “Cabezos”, Dacia and “Fantasma”) to south off the Canary Islands (Eco/Endeavour), between latitudes 19°N and 35°N, using bottom longlines. The main target species were demersal species such as Wreckfish (Polyprion americanus) or Splendidalfonsino (Beryx splendens). An observer on board recorded the bycatch of Vulnerable Marine Ecosystems (VME) indicator species in order to evaluate the potential adverse impact of bottom fishing activities on VME and samples of the specimens for later identification in the laboratory were stored. The main indicator species found were cold-water corals (black corals, scleractinians and gorgonians) and sponges, species broadly associated with seamounts. The shallower banks, Ampere and Dacia in the north and centre of the area, show the greater biodiversity and the higher percentage of presence of VME indicator species (52% and 53% of the sets respectively), followed by Endeavour (South of the Canary Islands), 36.4%. In these three banks the species distribution is strongly related to depth, finding Antipatharia (mainly Stichopathes sp) and Scleractinia (Dendrophyllia cornigera and D. ramea) in shallower depths and Porifera (Neophryssospongia nolitangere, Leiodermatium lynceus and Asconema setubalense) in deeper bottoms. Species of the Porifera group are present in all banks except of so-called ”Cabezos”

Defining the importance of landscape metrics for large branchiopod biodiversity and conservation: the case of the Iberian Peninsula and Balearic Islands

The deficiency in the distributional data of invertebrate taxa is one of the major impediments acting on the bias towards the low awareness of its conservation status. The present study sets a basic framework to understand the large branchiopods distribution in the Iberian Peninsula and Balearic Islands. Since the extensive surveys performed in the late 1980s, no more studies existed updating the information for the whole studied area. The present study fills the gap, gathering together all available information on large branchiopods distribution since 1995, and analysing the effect of human population density and several landscape characteristics on their distribution, taking into consideration different spatial scales (100 m, 1 km and 10 km). In overall, 28 large branchiopod taxa (17 anostracans, 7 notostracans and 4 spinicaudatans) are known to occur in the area. Approximately 30% of the sites hosted multiple species, with a maximum of 6 species. Significant positive co-occurring species pairs were found clustered together, forming 4 different associations of large branchiopod species. In general, species clustered in the same group showed similar responses to analysed landscape characteristics, usually showing a better fit at higher spatial scales.Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [401045/2014-5]Spanish Ministry of Education, Culture and Sport [FPU014/06783]info:eu-repo/semantics/publishedVersio

Estudios de marcado y recaptura de especies marinas

Los resultados obtenidos del marcado y posterior recaptura de los ejemplares son una herramienta muy valiosa para contribuir a mejorar el conocimiento de la biología y ecología de una especie, examinando ciertos aspectos como son: el crecimiento, los movimientos o migraciones, la mortalidad o supervivencia, la abundancia y distribución de la especie, el hábitat y diferenciación de poblaciones o stocks. Actualmente la técnica de marcado se aplica a muchas especies, tanto terrestres como marinas, pertenecientes a diversos grupos zoológicos: peces, crustáceos, reptiles, moluscos y mamíferos. Este libro repasa algunos ejemplos de marcado de especies marinas de interés comercial. No todas las especies pueden ser marcadas, porque es necesario cumplir una serie de requisitos para poder llevar a cabo con éxito un experimento de marcado. En uno de los apartados de esta guía, se describen los distintos aspectos a tener en cuenta para obtener buenos resultados. Se describen los principales proyectos de marcado actualmente en ejecución o en marcha llevados a cabo por el Instituto Español de Oceanografía (IEO). En primer lugar, se describe brevemente la especie, su distribución, crecimiento, reproducción, alimentación, etc. A continuación, se presenta la información del marcado, es decir, campañas realizadas, número de ejemplares marcados y algunos de los resultados obtenidos hasta la fecha a partir de las recapturas disponibles. En algunas especies, los programas de marcado se llevan realizando desde hace más de 20 años, como es el caso del atún rojo, por lo que la información disponible es bastante amplia. En otros casos por el contrario como la merluza, los proyectos son relativamente recientes, no obstante los resultados son bastante interesantes y prometedores.Nowadays many different marine animals are being tagged. This book summarizes recent tagging programs carried out by the Spanish Institute of Oceanography (IEO). Although the objectives of these various studies mainly depend on the species and each project in particular, the general aim is to better understand the biology and ecology of these animals the structure and dynamics of their populations and their capacity to respond to human activities. This book provides an overview of different aspects of this technique such as a brief history of tagging, the types of tags currently used, including both conventional and electronic tags, where and how to put them on the marine animals, some recommendations regarding how to perform a tagging survey and where to go or what to do if anyone recovers a tagged fish or marine animal. The book then summarizes the main species tagged by the IEO, making a short description of their biology followed by some of the results obtained from tagging studies undertaken until now. Other applications are to know the spatial distribution (spawning or feeding areas), estimate growth parameters, mortality and survival rates, longevity, the size of the population or identifying stocks. Nowadays the advances in electronics have also open new fields such us the possibility of tracking an animal and knowing its habitat preferences and behaviour. Besides some of these tags have the capacity of recording this information during long periods and sending the data from long distances even without the need to recover the animal. Tagging activities constitute a very useful tool to improve the knowledge of many species and contribute to their management and conservation. For that reason this methodology is included in many IEO projects in which other activities like the monitoring of the fishery (landings, fishing effort, fleet characteristics, fishing areas, biological sampling, etc.) are carried out. Some projects are related with coastal pelagic fisheries including anchovy, sardine and mackerel or oceanic pelagic fisheries like tuna and billfish species and pelagic sharks. Others are focused on benthic and demersal species such as hake, black spot seabream, anglerfish, flatfish, etc. Nevertheless not all species can be tagged, as they have to survive being caught and handled before being release. For this reason, tagging techniques may not easily be applied to some species.Versión del edito

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections

IMPORTANCE The consumption of broad-spectrum drugs has increased as a consequence of the spread of multidrug-resistant (MDR) Escherichia coli. Finding alternatives for these infections is critical, for which some neglected drugs may be an option. OBJECTIVE To determine whether fosfomycin is noninferior to ceftriaxone or meropenem in the targeted treatment of bacteremic urinary tract infections (bUTIs) due to MDR E coli. DESIGN, SETTING, AND PARTICIPANTS This multicenter, randomized, pragmatic, open clinical trial was conducted at 22 Spanish hospitals from June 2014 to December 2018. Eligible participants were adult patients with bacteremic urinary tract infections due to MDR E coli; 161 of 1578 screened patients were randomized and followed up for 60 days. Data were analyzed in May 2021. INTERVENTIONS Patients were randomized 1 to 1 to receive intravenous fosfomycin disodium at 4 g every 6 hours (70 participants) or a comparator (ceftriaxone or meropenem if resistant; 73 participants) with the option to switch to oral fosfomycin trometamol for the fosfomycin group or an active oral drug or pa renteral ertapenem for the comparator group after 4 days. MAIN OUTCOMES AND MEASURES The primary outcome was clinical and microbiological cure (CMC) 5 to 7 days after finalization of treatment; a noninferiority margin of 7% was considered. RESULTS Among 143 patients in the modified intention-to-treat population (median [IQR] age, 72 [62-81] years; 73 [51.0%] women), 48 of 70 patients (68.6%) treated with fosfomycin and 57 of 73 patients (78.1%) treated with comparators reached CMC (risk difference, -9.4 percentage points; 1-sided 95% CI, -21.5 to infinity percentage points; P = .10). While clinical or microbiological failure occurred among 10 patients (14.3%) treated with fosfomycin and 14 patients (19.7%) treated with comparators (risk difference, -5.4 percentage points; 1-sided 95% CI. -infinity to 4.9; percentage points; P = .19), an increased rate of adverse event-related discontinuations occurred with fosfomycin vs comparators (6 discontinuations [8.5%] vs 0 discontinuations; P = .006). In an exploratory analysis among a subset of 38 patients who underwent rectal colonization studies, patients treated with fosfomycin acquired a new ceftriaxone-resistant or meropenem-resistant gram-negative bacteria at a decreased rate compared with patients treated with comparators (0 of 21 patients vs 4 of 17 patients [23.5%]; 1-sided P = .01). CONCLUSIONS AND RELEVANCE This study found that fosfomycin did not demonstrate noninferiority to comparators as targeted treatment of bUTI from MDR E coli; this was due to an increased rate of adverse event-related discontinuations. This finding suggests that fosfomycin may be considered for selected patients with these infections

A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)

Meeting abstrac

100 años investigando el mar. El IEO en su centenario (1914-2014).

Se trata de un libro que pretende divulgar a la sociedad las principales investigaciones multidisciplinares llevadas a cabo por el Instituto Español de Oceanografía durante su primer siglo de vida, y dar a conocer la historia del organismo, de su Sede Central y de los nueve centros oceanográficos repartidos por los litorales mediterráneo y atlántico, en la península y archipiélagos.Kongsberg 20